Missed GME or NVDA? Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
CVRX Stock Forecast 2025-2026
$6.19
Current Price
$141.83M
Market Cap
Buy 6
Hold 0
Sell 1
Wall St Analyst Ratings
Distance to CVRX Price Targets
+126.2%
To High Target of $14.00
+85.8%
To Median Target of $11.50
+13.1%
To Low Target of $7.00
CVRX Price Momentum
+29.8%
1 Week Change
+0.7%
1 Month Change
-23.4%
1 Year Change
-51.1%
Year-to-Date Change
-66.6%
From 52W High of $18.55
+44.0%
From 52W Low of $4.30
📉 MARKET SELLOFF ALERT
10 Quality Stocks Worth Considering Now
Researching CVRx (CVRX) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on CVRX and similar high-potential opportunities.
Latest CVRX Stock Price Targets & Analyst Predictions
Based on our analysis of 8 Wall Street analysts, CVRX has a bullish consensus with a median price target of $11.50 (ranging from $7.00 to $14.00). The overall analyst rating is Strong Buy (8.9/10). Currently trading at $6.19, the median forecast implies a 85.8% upside. This outlook is supported by 6 Buy, 0 Hold, and 1 Sell ratings.
The most optimistic forecast comes from Frank Takkinen at Lake Street, projecting a 126.2% upside. Conversely, the most conservative target is provided by Robbie Marcus at JP Morgan, suggesting a 13.1% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
CVRX Analyst Ratings
6
Buy
0
Hold
1
Sell
CVRX Price Target Range
Low
$7.00
Average
$11.50
High
$14.00
Current: $6.19
Latest CVRX Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for CVRX.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| May 9, 2025 | JP Morgan | Robbie Marcus | Underweight | Downgrade | $7.00 |
| May 9, 2025 | Piper Sandler | Matt O'Brien | Overweight | Maintains | $12.00 |
| Apr 8, 2025 | Lake Street | Frank Takkinen | Buy | Maintains | $14.00 |
| Apr 8, 2025 | Canaccord Genuity | William Plovanic | Buy | Maintains | $18.00 |
| Feb 5, 2025 | Piper Sandler | Matt O'Brien | Overweight | Maintains | $20.00 |
| Feb 5, 2025 | Canaccord Genuity | William Plovanic | Buy | Maintains | $23.00 |
| Jan 17, 2025 | Craig-Hallum | Alexander Nowak | Buy | Maintains | $22.00 |
| Jan 14, 2025 | William Blair | Margaret Kaczor | Outperform | Upgrade | $0.00 |
| Dec 9, 2024 | Canaccord Genuity | William Plovanic | Buy | Maintains | $22.00 |
| Nov 4, 2024 | Craig-Hallum | Alexander Nowak | Buy | Maintains | $20.00 |
| Oct 30, 2024 | Canaccord Genuity | William Plovanic | Buy | Maintains | $17.00 |
| Oct 30, 2024 | Piper Sandler | Matt O'Brien | Overweight | Reiterates | $16.00 |
| Oct 30, 2024 | Lake Street | Frank Takkinen | Buy | Maintains | $15.00 |
| Oct 23, 2024 | Cantor Fitzgerald | Ross Osborn | Overweight | Reiterates | $14.00 |
| Sep 10, 2024 | Cantor Fitzgerald | Ross Osborn | Overweight | Initiates | $14.00 |
| Aug 26, 2024 | Lake Street | Frank Takkinen | Buy | Reiterates | $12.00 |
| Jul 30, 2024 | Canaccord Genuity | William Plovanic | Buy | Maintains | $15.00 |
| Jul 30, 2024 | Piper Sandler | Matt O'Brien | Overweight | Maintains | $13.00 |
| Jul 11, 2024 | Lake Street | Frank Takkinen | Buy | Maintains | $12.00 |
| Jul 11, 2024 | Craig-Hallum | Alexander Nowak | Buy | Maintains | $15.00 |
CVRx, Inc. (CVRX) Competitors
The following stocks are similar to CVRx based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
CVRx, Inc. (CVRX) Financial Data
CVRx, Inc. has a market capitalization of $141.83M with a P/E ratio of -2.3x. The company generates $52.87M in trailing twelve-month revenue with a -97.5% profit margin.
Revenue growth is +14.7% quarter-over-quarter, while maintaining an operating margin of -108.8% and return on equity of -76.0%.
Valuation Metrics
Market Cap
$141.83M
Enterprise Value
$85.68M
P/E Ratio
-2.3x
PEG Ratio
-2.5x
Price/Sales
2.7x
Growth & Margins
Revenue Growth (YoY)
+14.7%
Gross Margin
+83.5%
Operating Margin
-108.8%
Net Margin
-97.5%
EPS Growth
+14.7%
Financial Health
Cash/Price Ratio
+63.6%
Current Ratio
14.8x
Debt/Equity
72.7x
ROE
-76.0%
ROA
-26.9%
💰 DON'T MISS THIS OPPORTUNITY
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.
CVRx, Inc. (CVRX) Business Model
About CVRx, Inc.
What They Do
Develops innovative therapies for cardiovascular conditions.
Business Model
CVRx, Inc. generates revenue by selling its primary product, the Barostim Neo, a neuromodulation device that enhances heart function by stimulating baroreceptors to regulate blood pressure. The company collaborates with healthcare providers and institutions to expand its market presence and improve patient outcomes.
Additional Information
Founded with a strong commitment to patient care, CVRx is headquartered in Minneapolis, Minnesota, and is focused on research and development for advancing non-invasive treatment options in the cardiovascular segment.
Company Information
Sector
Healthcare
Industry
Medical Devices
Employees
206
CEO
Mr. Kevin Hykes
Country
United States
IPO Year
2021
Website
www.cvrx.comCVRx, Inc. (CVRX) Latest News & Analysis
Featured Analysis
Powered by
Zacks Investment Research
CVRx (CVRX) Reports Q1 Loss, Tops Revenue Estimates
CVRx (CVRX) delivered earnings and revenue surprises of 5.36% and 0.39%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
May 08, 2025
By Zacks Equity Research
Tale of the Tape
Latest News
Quick Summary
CVRx, Inc. will hold its Q1 2025 Earnings Conference Call on May 8, 2025, at 4:30 PM ET, featuring CEO Kevin Hykes and CFO Jared Oasheim.
Why It Matters
CVRx's Q1 2025 earnings call provides insights into its financial performance and future projections, influencing stock valuation and investor sentiment.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
CVRx reported a quarterly loss of $0.53 per share, better than the expected loss of $0.56, and an improvement from a loss of $1.04 per share a year earlier.
Why It Matters
CVRx's smaller quarterly loss than expected signals improving financial health, potentially boosting investor confidence and influencing stock performance positively.
Source: Zacks Investment Research
Market Sentiment:
Negative
Quick Summary
CVRx (CVRX) is not expected to meet the criteria for a potential earnings beat in its upcoming report, indicating cautious investor sentiment ahead of the release.
Why It Matters
CVRx's potential inability to meet earnings expectations may signal weak financial performance, affecting stock prices and investor confidence.
Source: Zacks Investment Research
Market Sentiment:
Negative
CVRx to Report First Quarter 2025 Financial and Operating Results and Host Conference Call on May 8, 2025
22 days ago
Quick Summary
CVRx, Inc. (NASDAQ: CVRX) will release its Q1 2025 financial results on May 8, 2025, after market close, with a conference call scheduled at 4:30 PM ET.
Why It Matters
CVRx's upcoming earnings release and conference call could impact its stock price, providing insights into financial health and operational performance, influencing investor sentiment and decisions.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
First quarter revenue is projected to be about $12.3 million, reflecting a 15% growth compared to the first quarter of 2024.
Why It Matters
The projected 15% revenue growth signals strong demand and operational performance, potentially enhancing investor confidence and positively impacting stock valuation.
Source: GlobeNewsWire
Market Sentiment:
Neutral
Quick Summary
CVRx Inc. stock has fallen 40%, but analysts see a buying opportunity due to Barostim's strong clinical results and a $2.2 billion total addressable market.
Why It Matters
CVRx Inc.'s 40% stock drop creates a potential buying opportunity, driven by strong clinical results and a $2.2 billion market potential for Barostim, suggesting future value recovery.
Source: Seeking Alpha
Market Sentiment:
Positive
Frequently Asked Questions About CVRX Stock
What is CVRx, Inc.'s (CVRX) stock forecast for 2025?
Based on our analysis of 8 Wall Street analysts, CVRx, Inc. (CVRX) has a median price target of $11.50. The highest price target is $14.00 and the lowest is $7.00.
Is CVRX stock a good investment in 2025?
According to current analyst ratings, CVRX has 6 Buy ratings, 0 Hold ratings, and 1 Sell ratings. The stock is currently trading at $6.19. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for CVRX stock?
Wall Street analysts predict CVRX stock could reach $11.50 in the next 12 months. This represents a 85.8% increase from the current price of $6.19. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is CVRx, Inc.'s business model?
CVRx, Inc. generates revenue by selling its primary product, the Barostim Neo, a neuromodulation device that enhances heart function by stimulating baroreceptors to regulate blood pressure. The company collaborates with healthcare providers and institutions to expand its market presence and improve patient outcomes.
What is the highest forecasted price for CVRX CVRx, Inc.?
The highest price target for CVRX is $14.00 from Frank Takkinen at Lake Street, which represents a 126.2% increase from the current price of $6.19.
What is the lowest forecasted price for CVRX CVRx, Inc.?
The lowest price target for CVRX is $7.00 from Robbie Marcus at JP Morgan, which represents a 13.1% increase from the current price of $6.19.
What is the overall CVRX consensus from analysts for CVRx, Inc.?
The overall analyst consensus for CVRX is bullish. Out of 8 Wall Street analysts, 6 rate it as Buy, 0 as Hold, and 1 as Sell, with a median price target of $11.50.
How accurate are CVRX stock price projections?
Stock price projections, including those for CVRx, Inc., are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: May 16, 2025 1:07 PM UTC